Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model

详细信息    查看全文

• 作者：Nidal Muhanna ; MD ; PhD^a ; ^b ; ^c ; ¹ ; Adam Mepham^e ; ¹ ; Reza M. Mohamadi ; PhD^d ; Harley Chan ; PhD^a ; Tahsin Khan^a ; Margarete Akens ; PhD^a ; Justin D. Besant^e ; Jonathan Irish ; MD ; MSc^a ; ^b ; ^c ; ^{jonathan.irish@uhn.ca" class="auth_mail" title="E-mail the corresponding author} ; Shana O. Kelley ; PhD^d ; ^e ; ^f ; ^{shana.kelley@utoronto.ca" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Nanoparticle ; Circulating tumor cells ; Microfluidics ; Rabbit cancer model ; Cell sorting
• 刊名：Nanomedicine: Nanotechnology, Biology and Medicine
• 出版年：2015
• 出版时间：October 2015
• 年：2015
• 卷：11
• 期：7
• 页码：1613-1620
• 全文大小：818 K

文摘

Circulating tumor cells (CTCs) can be used as markers for the detection, characterization, and targeted therapeutic management of cancer. We recently developed a nanoparticle-mediated approach for capture and sorting of CTCs based on their specific epithelial phenotype. In the current study, we investigate the phenotypic transition of tumor cells in an animal model and show the correlation of this transition with tumor progression. VX2 tumor cells were injected into rabbits, and CTCs were evaluated during tumor progression and correlated with computerized tomography (CT) measurements of tumor volume. The results showed a dramatic increase of CTCs during the four weeks of tumor growth. Following resection, CTC levels dropped but then rebounded, likely due to lymph node metastases. Additionally, CTCs showed a marked loss of the epithelial cell adhesion molecule (EpCAM) relative to precursor cells. In conclusion, the device accurately traces disease progression and CTC phenotypic shift in an animal model.

From the Clinical Editor

The detection of circulating tumor cells (CTCs) has been used to predict disease prognosis. In this study, the authors developed a nanoparticle-mediated platform based on microfluidics to analyze the differential expressions of epithelial cell adhesion molecule (EpCAM) on CTCs in an animal model. It was found that the loss of EpCAM correlated with disease progression. Hence, the use of this platform may be further applied in other cancer models in the future.